|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 96, 735-755, Copyright © 1990 by The Rockefeller University Press
ARTICLES |
RW Scherer and GE Breitwieser
Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
The muscarinic acetylcholine receptor (mAChR)-stimulated, inwardly rectifying K+ current (IK [ACh]) was examined in single bullfrog atrial cells using the whole-cell patch clamp technique. IK[ACh] was activated either by bath addition of 1 microM ACh or via activation of the G protein, Gk, with guanosine-gamma-thiotriphosphate (GTP gamma S). Arachidonic acid (AA) modulated IK[ACh] under both conditions. AA decreased mAChR-stimulated IK[ACh] and increased the rate of decay from the peak current (desensitization). In addition, AA affected GTP gamma S-activated IK[ACh] by modulation of Gk. The effects of AA and its metabolites on Gk were assessed by examining their effects on both the basal rate of Gk activation by GTP gamma S, and the mAChR-mediated increase in activation rate produced by nanomolar ACh. AA increased the basal rate of GTP gamma S-mediated IK[ACh] activation, but reduced the ACh-induced augmentation of this rate. All of the effects of AA on GTP gamma S-mediated IK[ACh] activation were produced by metabolites. A lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA), decreased the basal and ACh-enhanced rate of IK[ACh] activation in both the presence and absence of exogenous AA. In contrast, indomethacin (INDO), a cyclooxygenase inhibitor, increased the basal rate of IK[ACh] activation by GTP gamma S in both the presence and absence of exogenous AA, and reversed the effects of AA on the ACh-augmented basal rate. AA metabolites produced via lipoxygenase and cyclooxygenase pathways thus have opposing effects on the signal transduction pathway from mAChR to IK[ACh]. We directly tested a lipoxygenase pathway metabolite, LTC4, on GTP gamma S-mediated IK[ACh] activation and found that it not only overcame the inhibitory effects of NDGA, but also increased both the basal and ACh-augmented rate of IK[ACh] activation. From these data, we propose that AA metabolites modulate the function of Gk by altering its kinetic properties.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Spehr, H. Hatt, and C. H. Wetzel Arachidonic Acid Plays a Role in Rat Vomeronasal Signal Transduction J. Neurosci., October 1, 2002; 22(19): 8429 - 8437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, D. Liu, L. Heath, D. M. Meyers, D. S. Krafte, P. K. Wagoner, C. P. Silvia, W. Yu, and M. E. Curran Direct Activation of an Inwardly Rectifying Potassium Channel by Arachidonic Acid Mol. Pharmacol., April 16, 2001; 59(5): 1061 - 1068. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Marinero, S. Ropero, B. Colas, J. C. Prieto, and M. P. Lopez-Ruiz Modulation of Guanosine Triphosphatase Activity of G Proteins by Arachidonic Acid in Rat Leydig Cell Membranes Endocrinology, March 1, 2000; 141(3): 1093 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kim and A. Pleumsamran Cytoplasmic Unsaturated Free Fatty Acids Inhibit Atp-Dependent Gating of the G Protein-Gated K+ Channel J. Gen. Physiol., March 1, 2000; 115(3): 287 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wu, W. Chen, E. Murphy, S. Gabel, K. B. Tomer, J. Foley, C. Steenbergen, J. R. Falck, C. R. Moomaw, and D. C. Zeldin Molecular Cloning, Expression, and Functional Significance of a Cytochrome P450 Highly Expressed in Rat Heart Myocytes J. Biol. Chem., May 9, 1997; 272(19): 12551 - 12559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Ivanova-Nikolova and G. E. Breitwieser Effector Contributions to G{beta}{gamma}-mediated Signaling as Revealed by Muscarinic Potassium Channel Gating J. Gen. Physiol., February 1, 1997; 109(2): 245 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Mjaatvedt, D E Cabin, S E Cole, L J Long, G E Breitwieser, and R H Reeves Assessment of a mutation in the H5 domain of Girk2 as a candidate for the weaver mutation. Genome Res., December 1, 1995; 5(5): 453 - 463. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Murphy, W. Glasgow, T. Fralix, and C. Steenbergen Role of Lipoxygenase Metabolites in Ischemic Preconditioning Circ. Res., March 1, 1995; 76(3): 457 - 467. [Abstract] [Full Text]
|
|
|
|
